Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

There's been talk that the U.S. may reschedule cannabis from a Schedule I substance down to Schedule III. Rescheduling would be a positive development for the industry, but it's not the same as outright legalization.

Think Rescheduling Marijuana in the U.S. Will Help Canadian Pot Stocks? Tilray Brands' CEO Doesn't Agree

Building on the trailblazing success of SweetWater's Gummies line, 'Half-A-Gummie' IPA emerges as a natural evolution in SweetWater's pursuit of innovation

Crafted for the People: SweetWater's New 'Half-A-Gummie' IPA Meets Consumer Demand for Fruity, Easy-Drinking Beers

Tilray just announced several new varieties of cannabis-infused beverages for its two leading brands in Canada. The market is celebrating the news, coupled with encouraging inflation data and Tilray's recent beer brand acquisitions.

Why Tilray Brands Stock Jumped Today

ChargePoint Holdings

CRISPR Therapeutics

Medtronic

Rocket Lab USA

SharkNinja Inc

Vertex Pharmaceuticals

One of my favorite investment strategies when seeking forever stocks is to look to past trends that turned stale. Think of some of the hottest sectors in the past five years that saw massive investor interest before falling back to Earth.

Invest in the Future With These 7 Forever Stocks

XMG Cannabis Brand Launches New Flavour Packed Drinks from its XMG+ Line Mollo Brand Releases New Cannabis Craft Brews Tilray Holds Strong Market Share Position in Recreational Cannabis Beverages in Canada TORONTO, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced a bold new range of cannabis-infused beverages from its renowned brands XMG and Mollo . Recognized for their diverse flavours and innovative cannabinoid profiles, including THC, CBG, and CBD, these brands are reshaping the cannabis beverage market with unparalleled variety and quality.

Tilray Brands Expands Cannabis Beverage Portfolio With New THC, CBG and CBD Drink Innovations by Top-Performing Canadian Brands

Green Thumb Industries Inc.

Innovative Industrial Properties

Cannabis stocks could see higher highs in 2024. For one, according to a recent Gallup survey, 70% of Americans back legalization.

3 Cannabis Stocks You'll Regret Not Buying Soon: November 2023

Cronos Group

SNDL Inc.

Marijuana stocks could see better trading come this new year. The reason for this is due to a couple of variables. For one it is a new year and often times the excitement can lead to positive speculation creating a pick-up in trading. Also, companies are working on many new projects and business deals that would further develop the cannabis industry. Even though there is no federal reform in place companies have been producing some innovative products and services.

Marijuana Stocks For Weekly Watch List 2023

DraftKings

MINISO Group Holding

It's common to find healthy business model companies that are addressing large markets but also struggling with cash burn. Keeping a close watch on these firms is prudent, looking for fundamental improvements in cost cutting, changes in product-mix, and operating leverage.

3 Stocks to Buy for a Big Rally Backed by Improving Fundamentals

I recently included Tilray (NASDAQ: TLRY ) stock in a list of three cannabis stocks to buy now. My rationale for recommending investors buy was I thought it could be successful in its diversification plan beyond cannabis with beer and spirits.

Facing Facts: Tilray's Diversification Dilemma Spells Risk for TLRY Stock Investors

TLRY stock is nearing lows after the company reported a larger loss and higher sales in its latest earnings report.

Is TLRY Stock A Buy As Another State Legalizes Recreational Marijuana?

TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that its best-selling Canadian cannabis brand, Good Supply ™, just unveiled a new seasonal campaign, ‘Get Blitzen'd'. Amplifying the festive cheer, Good Supply introduces its first-ever limited-edition 'Holiday Helpers' 36-pack of pre-rolls and 'The Grump' - a special holiday offering of the acclaimed MONSTERS ™ 1,000mg infused pre-roll.

Good Supply™ Cannabis Launches 'Get Blitzen'd' Holiday Campaign and New Limited-Edition Products Across Canada

Canopy Growth

Canopy Growth has been trimming costs as it shifts towards an "asset-light" operating model. Tilray has been acquiring beverage companies and brands in an effort to further diversify its operations.

Tilray Brands vs. Canopy Growth: Which Cannabis Company Has the Better Long-Term Strategy?

AdvisorShares Pure US Cannabis ETF

When Joe Biden campaigned for president in 2020, there was no hope for cannabis stocks. Biden had been a hardliner on drug policy for most of the years he spent serving as a Senator.

Investing in the Cannabis Industry: 3 Stocks to Buy Now

Tilray's liquidity base, diversification from beverages, and positive profitability outlook have placed it ahead of its peers. Despite a transformative year in calendar 2023, TLRY stock is down 34% year-to-date. The stock is trading at roughly 2x the level of its peers on a price-to-sales multiple basis. I expect this premium to remain sticky.

Tilray Is Better Than Its Cannabis Peers

Bitfarms Ltd

Polestar Automotive Holding UK PLC

The broad market conditions remain challenging because of macroeconomic and geopolitical headwinds. That's unlikely to stop trading and speculative activity across asset classes.

3 Speculative Stocks for 100% Returns at the Blink of an Eye

Tilray Brands (NASDAQ: TLRY) stock price has been in a freefall this year as concerns about the cannabis industry. The shares crashed to a low of $1.83 on Tuesday, down by more than 46% from the highest point in September.

Tilray Brands (TLRY) stock price could plunge by 17% soon

The Canadian marijuana market and top marijuana stocks are still filled with investment opportunities as November 2023 draws in both seasoned traders and novices. The industry's unrelenting expansion has been nothing short of extraordinary, driven by rising legality and soaring demand. Since cannabis was first legalized for recreational use in 2018, Canada's cannabis market has advanced significantly. Its booming retail sector, elite cultivators, and well-established infrastructure contribute to its continued success. Growing exports abroad have also helped the industry, establishing Canada as a significant cannabis-producing hub.

November's Top Canadian Cannabis Stocks: A Closer Look

Aurora Cannabis

The cannabis market has been marred by long swings of optimism and even longer swings of underwhelming results. Investors in the space have been burned time and again by stocks that promise massive returns from the fledgling sector that continues to draw hope from a patchwork of legal regulations.

Is the Cannabis Craze Cooling Off? Avoid These 3 Overvalued Stocks

IM Cannabis Corp

Village Farms International

Marijuana stock investors are keeping watch for the next investment opportunity. For some time there has been a rise in market volatility in the cannabis sector. This has been both positive and negative for shareholders and investors. The upside to volatility is that when there is a pullback it gives people a chance to find top marijuana stocks to buy. But it's the price point and how low shares typically cost. Now the upside is having a volatile rise in trading and this is when people would take profits.

Investing In Marijuana Stocks 2024

The current cannabis trends affecting the market are likely to continue to impact the sector in 2024. First, the legal environment appears to be becoming more friendly to the drug.

3 Trends in Cannabis Stocks to Watch for 2024

WM Technology

Chicago Atlantic Real Estate Finance

Scotts Miracle-Gro

Constellation Brands

Valley National

Cannabis stocks are well off past peaks. But that doesn't mean it's a dead – or dying – industry.

The DIY Cannabis Portfolio: 7 Stocks From Seed to Stem

NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Blue Point Brewing Company (“Blue Point”), a subsidiary of Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY and TSX: TLRY), is thrilled to announce the return of its highly anticipated 19th Annual Cask Ales Festival. The event, in partnership with Long Island Cares, is set to take place on Saturday, November 4th, and promises a mix of live music, local vendors, food trucks, and, of course, a wide array of cask ales from breweries around the country.

Blue Point Brewing Announces Cask Ales Festival and New Beer Lineup

Curaleaf Holdings, Inc.

Over the last few months, the allure of cannabis stocks has gained momentum. Since mid-2023, many top-tier cannabis companies have experienced rejuvenation in pricing and demand.

7 Cannabis Stocks to Buy Before They Burn Higher

Global X Cannabis ETF

Cannabis stocks will eventually see higher highs — with patience. Right now, we're waiting to see if the Drug Enforcement Administration (DEA) takes the U.S. Department of Health and Human Services' (HHS) advice to remove cannabis as a Schedule I drug, which could boost related stocks.

3 Cannabis Stocks to Buy Before the Big Breakout

Anghami

Recursion Pharmaceuticals

Speculative stocks are a risky proposition in today's market. With even the Standard and Practices (S&P) 500's stablest giants dropping, small-cap risky stocks don't stand a chance.

3 Extra-Speculative Stocks That Could Make You Very, Very Rich

News for Tilray Brands Stock (TLRY)